chevron_leftBack
As of 11 June 2026, Enzychem Lifesciences Corp. has a market cap of $50.36M USD, ranking #30523 globally and #1738 in South Korea.
It ranks #2753 in the Healthcare sector, and #158 in the Drug Manufacturers - Specialty & Generic industry.
Key Stats
Market Cap
$50.36MUSD
76.86B KRW
Enterprise Value
-$6.49MUSD
-9.9B KRW
Revenue (TTM)
$44.39MUSD
67.75B KRW
EBITDA (TTM)
-$9.92MUSD
-15.13B KRW
Net Income (TTM)
-$11.88MUSD
-18.13B KRW
EBITDA Margin
-22%
Profit Margin
-27%
PS Ratio
1.1
PB Ratio
0.6
Company Profile
Country (HQ)
Sector
Healthcare
CEO
Ki-Young Sohn
open_in_new
Employees
130
Founded
1999
Website
enzychem.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -2.7% | -7.1% | -28% | -40% | -16% | -16% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
183490
(주)엔지켐생명과학
ISIN: KR7183490002
Shares Out.:
Shares Outstanding:
74.869M1
Shares Float:
52.485M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
990 KRW |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Enzychem Lifesciences Corp.
Enzychem Lifesciences Corporation engages in developing novel small molecule therapeutics for patients with unmet needs for oncology, inflammatory, and severe respiratory diseases in South Korea. It is also developing EC-18, an oral small molecule for fibrotic diseases, such as nonalcoholic steatohepatitis; and in severe respiratory diseases as a potential therapy for COVID-19. The company was founded in 1999 and is headquartered in Seoul, South Korea.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
KRX: 317450
|
$541.45M
975%
826.36B KRW
|
8.4
|
|
KRX: 220100
|
$279.29M
455%
426.25B KRW
|
-
|
|
KRX: 200130
|
$219.51M
336%
335.01B KRW
|
-
|
|
KRX: 009290
|
$204.17M
305%
311.61B KRW
|
16.3
|
|
KRX: 194700
|
$167.94M
233%
256.31B KRW
|
7.4
|
|
KRX: 011040
|
$99.21M
97%
151.41B KRW
|
17.8
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
TLV: TEVA
|
$36.98B
73K%
108.92B ILS
|
24.2
|
|
NASDAQ: RVMD
|
$29.56B
59K%
|
-
|
|
SHE: 002001
|
$15.85B
31K%
107.34B CNY
|
16.0
|
|
NSE: CIPLA
|
$11.16B
22K%
1.06T INR
|
23.4
|
|
NSE: LUPIN
|
$11.04B
22K%
1.05T INR
|
22.7
|
|
SHE: 002653
|
$9.09B
18K%
61.6B CNY
|
80.6
|
chevron_leftBack